Type
. Failure of specific antigen presentation in lepromatous leprosy. Leprosy review [Internet]. 1986;57(1):78-9. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a19.pdf
Type
. Supplies of thalidomide for use in leprosy. Leprosy review [Internet]. 1986;57(1):76-7. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a17.pdf
Type
. Response to lepromin unaltered by application of zinc to the skin in lepromatous leprosy patients. Leprosy review [Internet]. 1986;57(1):72-3. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a14.pdf
Type
. Oily injections of dapsone; an acceptable form of treatment?. Leprosy review [Internet]. 1986;57(1):70-2. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a13.pdf
Type
. Dapsone syndrome occurring in two brothers. Leprosy review [Internet]. 1986;57(1):57-62. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a10.pdf
Type
. Adhesive zinc tape treatment of uncomplicated ulcers amongst leprosy outpatients. Leprosy review [Internet]. 1986;57(1):45-51. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a08.pdf
Type
. A study of drug interactions in leprosy--1. Effect of simultaneous administration of prothionamide on metabolic disposition of rifampicin and dapsone. Leprosy review [Internet]. 1986;57(1):33-7. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a06.pdf
Type
. The effect of dapsone in high and normal dosage on the clinical and cell-mediated immune status of patients with borderline (BT-BL) leprosy. Leprosy review [Internet]. 1986;57(1):19-26. Available from: http://leprev.ilsl.br/pdfs/1986/v57n1/pdf/v57n1a04.pdf
Type
. Side effects of levamisole. Indian journal of medical sciences. 1986;40(1):6-8.
Type
. Relative efficacy of commonly used clinical and laboratory methods for the diagnosis of leprosy. Indian journal of dermatology. 1986;31(1):7-11.